Urvattnat sjukvårdsförslag i USA

SwedenBio populärare än någonsin

Med 45 nytillkomna medlemmar senaste året blev det trångt på branschföreningens årsmöte igår. - Det här visar att vi verkligen behövs, sade SwedenBios vd Mats Berggren.

Faster sales but less profits for Probi

The probiotic company increases its turnover, and the net results are twice as large as last year.

Pfizer lays a chunky bid on Wyeth

The merger of two pharma giants is the largest industry deal so far this year. Pfizer will acquire Wyeth in a cash-and-stock transaction currently valued at approximately $68 billion. The Boards of Directors of both companies have said yes to the deal

Fusion between pharma giants?

It is rumoured that a fusion between Pfizer and Wyeth is in the process of happening.

Almost 150 will leave Coloplast

The Danish medtech company Coloplast negotiates headcount reductions, with a total number of almost 150 employees.

Lytix calls in cash

Norwegian company Lytix Biopharma closes a USD 1.4 million funding round to finance new antimicrobial and oncology lead compounds.

Abbott expands by acquisition

An acquisition gives Abbott a leadership position in another large and growing medical device segment.

Medicult disclaims Swedish offer

The Norwegian company Medicult's Board is highly sceptical to the yesterday announced Vitrolife offer.

Collaboration brings next generation drugs

Wyeth and Santaris Pharma announce a new alliance to develop RNA-based medicines.

Medicult acquires embryo scanner

The Danish company Medicult signs an agreement with Novocellus to gain access to embryo selection technology.

Danish discovery could help cardiac patients

The Danish researchers have developed a component that could make live easier forpatients with heart failure.

Meda gets access to Asia

The biotech giant Meda has recently acquires world-wide rights to the cancer breakthrough pain drug Onsolis.

Time to save for survival

The future is bright for the biotech industry. However, the companies need to cut costs immediately if they want to survive the rough economic times.